Using Aptamers for Cancer Biomarker Discovery

Table 1

Specificity of sgc8 aptamer for T-ALL cancer cells. binding capacity of the aptamer to the cells. 0: <10%; +: 10%–35%; ++: 35%–60%; +++: 60%–85%; ++++: >85%; APL: acute promyelocytic leukemia [17].

Cultured cell lines	sgc8
Molt-4 (T cell ALL)	++++
Sup-T1 (T cell ALL)	++++
Jurkat (T cell ALL)	++++
Sup-B15 (B cell ALL)	+
U266 (B cell myeloma)	0
Toledo (B cell lymphoma)	0
MO2058 (B cell lymphoma)	0
NB-4 (AML, APL)	0